Dermata Therapeutics, Inc. (DRMA) vs Reviva Pharmaceuticals Holdings, Inc. (RVPH)
- Dermata Therapeutics, Inc. DRMA 0.86 −5.49%
- Reviva Pharmaceuticals Holdings, Inc. RVPH 0.45 −6.25%
Dermata Therapeutics, Inc. and Reviva Pharmaceuticals Holdings, Inc. are both Biotechnology companies. Reviva Pharmaceuticals Holdings, Inc. is the larger, with a market value of $5.0M against $4.5M — 1.1× the size. Across the 9 metrics below, Reviva Pharmaceuticals Holdings, Inc. leads on 6 and Dermata Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | DRMA | RVPH | Biotechnology median |
|---|---|---|---|
| Gross margin | — | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (183.89%) | (176.60%) | (56.36%) |
| Return on assets | (139.93%) | (79.46%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack